For laboratory research use only. Not for human or animal consumption.
BioIntegrityResearch

Metabolic Signaling

AOD-9604

HGH Fragment 176-191

AOD-9604 (HGH Fragment 176-191)

Research context

AOD-9604 corresponds to residues 176–191 of human growth hormone with an added N-terminal tyrosine. Research examines lipolytic activity in adipocyte preparations independent of the growth-promoting activity associated with the full-length hormone.

Common assays: Adipocyte lipolysis quantification · Glycerol release · Receptor binding characterisation

Specification

DesignationHGH Fragment 176-191
Full nameAOD-9604 (HGH Fragment 176-191)
SequenceTyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
CAS number221231-10-3
Molecular formulaC78H123N23O23S2
Molecular weight1815.08 g/mol
Formats10 mL Vial
SolubilityBacteriostatic water, sterile water
StorageLyophilised: −20 °C. Reconstituted: 2–8 °C.
Current lotAOD10VAS0426

Published literature

Selected peer-reviewed references describing research involving this compound. Listed for reference only; inclusion is not a claim about any outcome.

  1. Heffernan M, Summers RJ, Thorburn A, et al.The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta-3 AR knock-out miceEndocrinology · 2001 Find on PubMed ↗

Common questions

How does AOD-9604 differ from full-length growth hormone?

It comprises only residues 176–191 plus an added tyrosine, and lacks the regions associated with growth-promoting and insulin-antagonistic activity in published characterisation.

Same pathway

Related compounds